AI assistant
Sending…
DEXCOM INC — Director's Dealing 2015
Jun 5, 2015
30198_dirs_2015-06-05_27e58198-5f39-4f2d-b9a0-103aabcf849e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2015-06-03
Reporting Person: ALTMAN STEVEN R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-06-03 | Common Stock | A | 4279.0 | $0.0010 | Acquired | 11417 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 15794 | Indirect |
Footnotes
F1: Share units are restricted and subject to vesting in one annual installment from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.
F2: Included in this number are 11,417 unvested restricted stock units, 4,279 of which were granted on June 3, 2015 and shall vest on June 3, 2016 and 7,138 unvested restricted stock units which were granted on November 4, 2013 and shall vest through November 4, 2016.
More from DEXCOM INC
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 17